Athira

Biotech firm Athira Pharma hit by class action lawsuits following image manipulation claims

by
Biotech firm Athira Pharma hit by class action lawsuits following image manipulation claims

Leen Kawas, CEO of Athira Pharma, went on leave earlier this month. (Athira Pharma photo) The lawsuits have started. Less than a week after the CEO of Athira Pharma was given a temporary leave of absence on allegations of altered images in the scientific papers she wrote, three class action lawsuits were filed on behalf … Read more

Athira Pharma CEO Leen Kawas placed on leave, shares sink more than 30%

by
Athira Pharma CEO Leen Kawas placed on leave, shares sink more than 30%

Leen Kawas, CEO of Athira Pharma, at the 2018 GeekWire Summit. (GeekWire Photo / Kevin Lisota) Leen Kawas, CEO of Athira Pharma, has been given a temporary leave of absence until the Seattle area biotechnology company completes a review that “emerged from Dr. Kawas emerges during his time at Washington State University ”. In after-hours … Read more